FDA investigates risk of blood cancers from bluebird bio's gene therapy-March 2024-www.financetom.com

FDA investigates risk of blood cancers from bluebird bio's gene therapy

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

FDA investigates risk of blood cancers from bluebird bio's gene therapy

Nov 27, 2024 8:57 AM

Nov 27 (Reuters) - The U.S. Food and Drug Administration

said on Wednesday it is investigating reports of blood cancers

in patients who were treated with bluebird bio's gene

therapy Skysona.

Previous page： DGCA extends suspension of scheduled international commercial passenger flights to Dec 31 Next page： HC declines to entertain 'half-baked' plea for immediate lockdown in Delhi

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

DGCA extends suspension of scheduled international commercial passenger flights to Dec 31

Nov 26, 2020

”In partial modification of circular dated 26.6.2020, the competent authority has further extended the validity of circular issued on the subject cited above regarding scheduled international commercial passenger services to/from India till 2359 hours (IST) of December 31, 2020,” the DGCA said in the circular.

HC declines to entertain 'half-baked' plea for immediate lockdown in Delhi

Nov 23, 2020

Delhi government additional standing counsel Gautam Narayan, during the brief hearing, told the bench that there is a specific direction from the central government to all states and Union Territories that no lockdown be imposed without its permission.

LPG subsidy for BPCL consumers to continue post-privatisation: Oil Minister

Nov 27, 2020

”Subsidy on LPG is paid to consumers directly and not to any company. So the ownership of the company that sells LPG is not of any material consequence,” Pradhan told PTI.

Byju's raising $200 million funding from BlackRock, T Rowe Price, say sources

Nov 22, 2020

The development comes about two months after Byju's had raised about $ 500 million (about Rs 3,672 crore) in a round that valued the company at $10.8 billion.